Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- HT942524Q0107
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- Q517 Pharmacy Services
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency is seeking proposals for the Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials. The solicitation (HT942524Q0107) includes the Minimum Essential Characteristics (MEC), Statement of Objective (SOO), and SOO Appendix A. Key requirements include conducting the specified clinical trials and meeting the objectives outlined in the SOO. The evaluation will focus on the offeror's technical approach, management plan, and past performance. Proposals are due by August 23, 2024.
This solicitation does not have a set-aside designation. There is no information provided about potential incumbents or current contractors. The solicitation does not specify an award value or budget range. The quantity of goods or timeline for services is not clearly defined. The place of performance is not explicitly stated.
Notice text
3 versions
Update #3 · Latest ·
Please see Solicitation Amendment HT9425-24-Q-0107 -00002 document to provide complete answers to all questions received.
Update #2 ·
Please see amended solicitation HT942524Q0107-01 to provide answers to questions receivedXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXPlease see Solicitation document HT942524Q0107 along with the attachments: Minimum Essential Characteristics (MEC), Statement of Objective (SOO) and SOO Appendix A
Update #1 ·
Please see Solicitation document HT942524Q0107 along with the attachments: Minimum Essential Characteristics (MEC), Statement of Objective (SOO) and SOO Appendix A
Notice history
| Notice | Type | Posted |
|---|---|---|
| Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials | Award Notice | |
| This notice | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity